ALX logo

ALEXANDER'S INC

ALXNYSE
πŸ† #2229 by market capEarnings Nov 2US Equity
$249.06β–² $1.14 (+0.46%)
πŸŒ… Pre-market$254.99β–² 2.38%Regular close Β· extended-hours price shown
πŸ””
Track ALX
Get earnings, price moves & breaking news on Telegram
Track
24hβ–² 0.5%
7dβ–² 0.5%
14dβ–² 6.7%
30dβ–² 0.9%
ytdβ–² 14.8%
1yβ–² 14.3%
🏦Market Cap
$1.27B
Small Cap
πŸ“ˆRevenue Growth (YoY)
-1.5%
Declining
πŸ“ŠGross Margin
47.4%
Healthy
πŸ’΅FCF Margin
13.1%
Healthy
βš–οΈP/S Ratio
5.9x
Fair
Otter Score
60
Fair

Trading Snapshot

Day Range
$248.52 – $252.75
52-Week Range
$201.28 – $289.43
Volume (shares)
55,601
Avg Volume (shares)
β€”
Shares Outstanding
5.1M
Next Earnings
2026-11-02

Fundamentals Snapshot

Annual Revenue
$213M
Last Q Revenue
$55M
P/E Ratio
7.5
P/S Ratio
5.9x
EPS (TTM)
$33.05
Dividend Yield
7.26%
Dilution (1yr)
+0.1%
ALX logo

ALEXANDER'S INC

ALX
Financial Trends
RevenueThe total money the company brought in from sales, before subtracting any costs.
$213Mβ–Ό βˆ’5.8% YoY
Gross MarginOf every $1 of sales, how much is left after the direct cost of making the product/service. Higher = more efficient.
16.1%β–Ό βˆ’83.9% YoY
Operating IncomeProfit from the core business after operating costs, but before interest and taxes. Negative means the core business isn’t profitable yet.
$65Mβ–Ό βˆ’20.3% YoY
Free Cash FlowCash left over after running the business and paying for equipment/capex. Negative means the company is burning cash.
$73Mβ–² +35.7% YoY
Shares OutstandingHow many shares exist. Rising means the company is issuing more shares, which dilutes (shrinks) each existing owner’s slice.
5.1Mβ–² +0.1% YoY
Net CashCash minus total debt. Positive = more cash than debt (financially strong); negative = more debt than cash (net debt).
βˆ’$815Mβ–Ό βˆ’$50M YoY
StockOtter Β· stockotter.space

About ALEXANDER'S INC

Alexander's, Inc., a real estate investment trust, possesses a portfolio comprising seven properties located across the broader New York City metropolitan region.

🦦

Otter Score Breakdown

How it's scoredFive components, each rated 1–5β˜… and equally weighted (20%), averaged to a 0–100 score:πŸ’Ž Quality β€” gross marginπŸš€ Growth β€” revenue YoYβš–οΈ Valuation β€” P/S ratio⚑ Momentum β€” 30-day price changeπŸ’§ Dilution β€” 1-yr share issuance (buybacks score higher)
πŸ’ŽQualityβ˜…β˜…β˜…β˜…β˜…
πŸš€Growthβ˜…β˜…β˜…β˜…β˜…
βš–οΈValuationβ˜…β˜…β˜…β˜…β˜…
⚑Momentumβ˜…β˜…β˜…β˜…β˜…
πŸ’§Dilutionβ˜…β˜…β˜…β˜…β˜…
Overall Score
Fair
60/100

Analyst Ratings

β“˜
Consensus
Sell
8 analysts
Strong Buy0
Buy0
Hold2
Sell5
Strong Sell1
Ratings as of Oct 2026

Latest News & Updates

GlobeNewsWireΒ·1d ago

Alexander's Declares Quarterly $4.50 Dividend on Common Shares

PARAMUS, N.J., Oct. 28, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that its Board of Directors has declared a regular quarterly dividend of $4.50 per share payable on November 20, 2026 to stoc

GlobeNewsWireΒ·10d ago

Alexander's Announces Third Quarter Earnings Release Date and Vornado Realty Trust Quarterly Conference Call

PARAMUS, N.J., Oct. 19, 2026 (GLOBE NEWSWIRE) -- Alexander's, Inc. (NYSE: ALX) today announced that it will file its quarterly report on Form 10-Q for the quarter ended September 30, 2026 with the U.S. Securities and Exc

Seeking AlphaΒ·23d ago

Mousetraps:Β 7 High-Yield REITs Risking Dividend Cuts

High-yield 'mousetrap' REITs consistently underperform, with average returns lagging the VNQ by 1090–1380 bps due to dividend cuts and price declines. Dividend Safety grades of F indicate a roughly 40% chance of a cut wi

Defense WorldΒ·23d ago

Alexander’s (NYSE:ALX) & Essential Properties Realty Trust (NYSE:EPRT) Head-To-Head Review

Alexander's (NYSE: ALX - Get Free Report) and Essential Properties Realty Trust (NYSE: EPRT - Get Free Report) are both real estate companies, but which is the better investment? We will compare the two companies based o

Defense WorldΒ·Sep 30

Alexander’s (NYSE:ALX) Stock Crosses Below 200 Day Moving Average – Should You Sell?

Alexander's, Inc. (NYSE: ALX - Get Free Report)'s share price passed below its 200-day moving average during trading on Tuesday. The stock has a 200-day moving average of $256.52 and traded as low as $247.02. Alexander's

GlobeNewsWireΒ·Sep 28

ALX Oncology Announces Nature Medicine Publication of ASPEN-06 Phase 2 Clinical Data Demonstrating Strong Responses and Durable Clinical Benefit with Evorpacept in HER2-Positive Gastric Cancer

Achieved 40.3% ORR with evorpacept plus trastuzumab, ramucirumab and paclitaxel versus 26.6% for control, with response rates increasing to 63.6% versus 23.1% among patients with high CD47 expression and retained HER2-po